SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq:ARTE), a medical technology company whose product ArteFill® is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of nasolabial fold or “smile line” wrinkles, announced that Michael K. Green has joined the Company as its Chief Financial Officer. He will have responsibility for all financial, accounting and investor relations activities, and will also manage the corporate facilities and the information technology departments.
